CrushSCI.com
93.6Average days
98Median days
38Fastest days
194Longest days
2322025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

74 days

Serum lipidomic remodeling associated with MASLD in Alström syndrome: comparison with BMI-matched obesity

Authors
Qianwen Zhang; Libo Wang; Yiguo Huang; Shiyang Gao; Lingwen Ying; Feihan Hu; Guoying Chang; Xiumin WangShow moreShow less
Affiliations
1. Department of Endocrinology, Metabolism and Genetics, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
Source PDF DOI Publisher page
87 days

Hepatitis B splicing-generated protein prevents tumor initiation but shapes a pro-tumor immune microenvironment in established HCC

Authors
Bouchra Lekbaby; Jules Sotty; Hoan Nguyen Dang; Jesus Emanuel Brunetti; Pierre Bablon; Céline Goy; Martin Larsen; Anne-Marie Cassard; Gabriel Perlemuter; Gwennhael Autret; Amine Majdi; Jérôme Galon; Jérémie Gautheron; Stefano Caruso; Julien Calderaro; Hélène Strick-Marchand; Julie Le Naour; Juliette Paillet; Gautier Stoll; Maria Pérez-Lanzon; Guido Kroemer; Jonathan Pol; Jérémy Augustin; Patrick SoussanShow moreShow less
Affiliations
1. Centre de Recherche de Saint-Antoine (CRSA), Sorbonne Université, Inserm U938, Paris, France; 2. Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; 3. Hepatology Department, Vietnam National Children’s Hospital, Hanoï, Vietnam; 4. Inserm U1135, Centre d’Immunologie des Maladies Infectieuses (CIMI), Sorbonne Université, Paris, France; 5. UMR966 Université Paris-Saclay, Inserm, Clamart, France; 6. AP-HP, Hepato-Gastroenterology and Nutrition, Hôpital Antoine-Béclère, Clamart, France; 7. Faculté Santé, Université de Paris Cité, Plateforme Imageries du Vivant, Inserm U970, Paris-Cardiovascular Research Center, France, Paris, France; 8. Centre de Recherche des Cordeliers, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France; 9. Laboratory of Integrative Immunology, Centre de Recherche Des Cordeliers, Université de Paris Cité, Sorbonne Université, Inserm U1138, Paris, France; 10. INSERM U955, Equipe 18, Institut Mondor de Recherche Biomédicale, Créteil, France; 11. Département de Pathologie, Hôpital Henri Mondor, APHP, Université Paris-Est Créteil, Créteil, France; 12. Innate Immunity Unit, Institut Pasteur, Paris, France; 13. INSERM U1223, Université de Paris, Sorbonne Paris Cité, Paris, France; 14. Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; 15. Department of Biology, Institut du Cancer Paris CARPEM, Hôpital Européen Georges Pompidou, Paris, France; 16. Département de Virologie, Sorbonne Université, APHP, GHU Paris-Est, Paris, France; 17. CRSA, Faculté Saint Antoine, Paris, FranceShow moreShow less
Source PDF DOI Publisher page
111 days

Metabolic risk factor burden and quantitative fibrosis are distinct prognostic modifiers in alcohol-associated liver cirrhosis

Authors
Mohit Varshney; Chhagan Bihari; Ravi Nishad; Sujata Prasad; Zeenat Naz; Sadaf Tariq; Chetan Ramesh Kalal; Archana Rastogi; Shiv K. SarinShow moreShow less
Affiliations
1. Institute of Liver and Biliary Sciences, Delhi, India; 2. Glen Eagles Hospital, Parel, IndiaShow moreShow less
Source PDF DOI Publisher page
112 days

Clinical characteristics, temporal trends, and predictors of liver transplantation-free survival in patients with autoimmune hepatitis: a nationwide Japanese registry study

Authors
Kazumichi Abe; Hiromasa Ohira; Atsushi Takahashi; Manabu Hayashi; Mikio Zeniya; Masanori Abe; Teruko Arinaga-Hino; Nobuhiro Nakamoto; Jun Inoue; Takanori Ito; Kazuhito Kawata; Yasuyuki Tamai; Atsumasa Komori; Akinobu Takaki; Jong-Hon Kang; Satoru Joshita; Hitomi Sezaki; Kazuhiko Koike; Ayano Inui; Yoshitaka Arase; Yasuteru Kondo; Shinji Shimoda; Kenichi Harada; Yasunari Nakamoto; Atsushi TanakaShow moreShow less
Affiliations
1. Department of Gastroenterology, Fukushima City, Japan; 2. Akasaka Sanno Medical Center, Tokyo, Japan; 3. Department of Community and General Medicine, Ehime University Graduate School of Medicine, Toon City, Japan; 4. School of Medical Technology, Kurume University School of Medicine, Kurume, Japan; 5. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan; 6. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan; 7. Department of Gastroenterology and Hepatology, Nagoya University Hospital, Nagoya, Japan; 8. Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Japan; 9. Department of Gastroenterology and Hepatology, Mie University, Tsu, Japan; 10. NHO Nagasaki Medical Center Omura, Omura, Japan; 11. Dentistry, and Pharmaceutical Sciences, Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Okayama, Japan; 12. Center for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan; 13. Department of Internal Medicine, NHI Yodakubo Hospital, Nagano, Japan; 14. Department of Hepatology, Toranomon Hospital, Tokyo, Japan; 15. Department of Gastroenterology and Hepatology, The Jikei University West Medical Center, Tokyo, Japan; 16. Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan; 17. Department of Gastroenterology and Hepatology, Tokai University School of Medicine, Isehara, Japan; 18. Department of Hepatology, Sendai Tokushukai Hospital, Sendai, Japan; 19. Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan; 20. Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan; 21. Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; 22. Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanShow moreShow less
Source PDF DOI Publisher page
62 days

Validating sarcopenia definitions in Asian patients with cirrhosis: a first and necessary step to characterizing muscle health

Authors
Jennifer C. LaiShow moreShow less
Affiliations
1. University of California, San Francisco (UCSF), United StatesShow moreShow less
Source PDF DOI Publisher page
49 days

Higher relapse rate after stopping tenofovir alafenamide compared with entecavir; but not tenofovir disoproxil fumarate in HBeAg-positive patients

Authors
Kuan-Hung Wan; Cheng-Yuan Peng; Yuan-Hung Kuo; Tsung-Hui Hu; Jing-Houng Wang; Chao-Hung Hung; Sheng-Nan Lu; Chien-Hung ChenShow moreShow less
Affiliations
1. Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; 2. Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan; 3. School of Medicine, China Medical University, Taichung, TaiwanShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Hepatology International take to review a manuscript?

As of 2026-11-18, CrushSCI has 25 complete review records for Hepatology International. The fastest paper went from submission to acceptance in 38 days (Plasma metabolic signatures of healthy dietary patterns and risk of metabolic dysfunction-associated steatotic liver disease and cirrhosis, received 2026-01-07, accepted 2026-02-14); the slowest took 194 days. The average is 93.6 days and the median is 98 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.